In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy

An injectable pH-sensitive nanoadjuvant is shown to induce effective pyroptosis of tumours, which, combined with the in situ photoactivable release of TLR agonists, generates a strong vaccine-like response to eradicate the tumour.